# Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome

> **NCT00356733** · PHASE3 · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 62 (actual)

## Conditions studied

- Heart Failure, Congestive
- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Erythropoietin administration

## Key facts

- **NCT ID:** NCT00356733
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2011-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356733, "Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00356733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*